4.2 Meeting Abstract

ASPIRO phase 1/2 gene therapy trial In X-linked myotubular myopathy: preliminary safety and efficacy findings

Journal

NEUROMUSCULAR DISORDERS
Volume 28, Issue -, Pages S91-S91

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.nmd.2018.06.240

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available